Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Overactive Bladder Conditions
4.2.2 Increasing Incidence of Urge Incontinence
4.3 Market Restraints
4.3.1 Health Risk associated with the Device
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 External SNS
5.1.2 Implantable SNS
5.2 By Application
5.2.1 Urge Incontinence
5.2.2 Urinary & Faecal Incontinence
5.2.3 Chronic Anal Fissure
5.2.4 Others
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Nuvectra
6.1.2 Medtronic
6.1.3 NeuroPace, Inc.
6.1.4 Laborie, Inc
6.1.5 Axonics Modulation Technologies, Inc.
6.1.6 Nevro Corp.
6.1.7 Boston Scientific Corporation
6.1.8 Synapse Biomedical Inc.
6.1.9 St. Jude Medical, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS